Suppr超能文献

接受丁丙诺啡治疗阿片类物质使用障碍且行剖宫产分娩的女性围产期及产后镇痛与疼痛情况

Peripartum and Postpartum Analgesia and Pain in Women Prescribed Buprenorphine for Opioid Use Disorder Who Deliver by Cesarean Section.

作者信息

O'Connor Alane B, Smith Joel, O'Brien Liam M, Lamarche Kaitlyn, Byers Nadine, Nichols Stephanie D

机构信息

Maine Dartmouth Family Medicine Residency/MaineGeneral Medical Center, Augusta, ME, USA.

Maine Medical Center, Portland, ME, USA.

出版信息

Subst Abuse. 2022 Jun 21;16:11782218221107936. doi: 10.1177/11782218221107936. eCollection 2022.

Abstract

AIM

Little is known about whether pain can be effectively managed in pregnant women with opioid use disorder (OUD) during delivery hospitalization, particularly those undergoing surgery and taking buprenorphine as medication for OUD (MOUD). To address this question, we compared pain scores and opioid analgesic utilization during delivery hospitalization in women taking their pre-hospital dose of buprenorphine who delivered by cesarean section to matched controls. To inform future research efforts, we also began to explore opioid analgesic utilization and pain scores by type of anesthesia as this variable is often not included in related literature.

METHODS

Retrospective matched cohort study of 46 women prescribed buprenorphine during pregnancy who delivered by cesarean section during a 7-year period.

RESULTS

When compared to matched controls, women taking their pre-hospital dose of buprenorphine undergoing cesarean section utilized more opioid analgesics as measured by morphine milligram equivalents (MME) (mean MME first 48 hours 153.0 mg vs 175.1 mg, respectively,  < .01) but had similar pain scores during delivery hospitalization. There was no difference in MME utilization by maternal dose of buprenorphine though sample sizes were small. Women on buprenorphine who received spinal anesthesia with morphine had mean pain scores that were 1.4 points lower ( = .01) during the first 48 hours than women on buprenorphine receiving other methods of anesthesia.

DISCUSSION AND CONCLUSIONS

Pregnant women taking their pre-hospital dose of buprenorphine throughout their surgical delivery hospitalization were able to achieve pain relief similar to women not on MOUD but had higher MME requirements. Our results add to the emerging body of evidence suggesting that individuals on MOUD can achieve adequate post-surgical pain management without adjusting their pre-hospital dose of buprenorphine. Further research is required to fully understand the optimal buprenorphine dosing regimen during surgical hospitalizations. Our results also provide important preliminary evidence that spinal anesthesia containing opioids can be used effectively in individuals with OUD requiring surgical intervention.

摘要

目的

对于患有阿片类药物使用障碍(OUD)的孕妇在分娩住院期间,尤其是那些接受手术并服用丁丙诺啡作为阿片类药物使用障碍药物治疗(MOUD)的患者,疼痛是否能得到有效管理知之甚少。为解决这个问题,我们比较了剖宫产分娩的女性在住院分娩期间服用院前剂量丁丙诺啡与匹配对照组的疼痛评分和阿片类镇痛药使用情况。为指导未来的研究工作,我们还开始按麻醉类型探索阿片类镇痛药使用情况和疼痛评分,因为相关文献中常常未包含这个变量。

方法

对46名在孕期开具丁丙诺啡处方且在7年期间剖宫产分娩的女性进行回顾性匹配队列研究。

结果

与匹配对照组相比,剖宫产时服用院前剂量丁丙诺啡的女性,以吗啡毫克当量(MME)衡量,使用了更多阿片类镇痛药(前48小时平均MME分别为153.0毫克和175.1毫克,P<0.01),但在分娩住院期间疼痛评分相似。尽管样本量较小,但按丁丙诺啡母体剂量计算的MME使用情况并无差异。接受吗啡脊髓麻醉的丁丙诺啡使用者在最初48小时内的平均疼痛评分比接受其他麻醉方法的丁丙诺啡使用者低1.4分(P = 0.01)。

讨论与结论

在整个手术分娩住院期间服用院前剂量丁丙诺啡的孕妇能够获得与未接受MOUD治疗的女性相似的疼痛缓解,但MME需求量更高。我们的结果进一步证明,接受MOUD治疗的个体无需调整院前丁丙诺啡剂量就能实现充分的术后疼痛管理。需要进一步研究以全面了解手术住院期间丁丙诺啡的最佳给药方案。我们的结果还提供了重要的初步证据,表明含阿片类药物的脊髓麻醉可有效用于需要手术干预的OUD患者。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验